Row
I
IMVTAI Stock Diagnostic Report
Immunovant CTO Jay Stout sells $75,099 in shares
Immunovant's Chief Technology Officer sold approximately $75,000 worth of stock, which may be interpreted as a negative signal.
View Source Article ↗AI CATALYST SCORE30 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
IMVT Analysis History (Last 30 Days)